Plitidepsin

Overview

Plitidepsin (Aplidine) is a potent anti-cancer agent by targeting eEF1A2 ( K D =80 nM). Plitidepsin possesses antiviral activity and is against SARS-CoV-2 with an IC 90 of 0.88 nM. Plitidepsin is usually used for multiple myeloma and advanced cancer research, and has the potential for COVID-19 research.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-16050
• CAS No.: 137219-37-5
• Molecular Formula: C57H87N7O15
• Molecular Weight: 1110.34
• Purity: 99.94%
• Storage: Sealed storage, away from moisture and light, under nitrogen. Powder -80°C, 2 years , -20°C, 1 year * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)
• Solubility: 2.5 mg/mL (2.25 mM); Suspended solution; Need ultrasonic
• Availability: In-stock

Source

Original product source